Skip to main content
Clinical Trials/JPRN-jRCT1041190094
JPRN-jRCT1041190094
Not yet recruiting
未知

Verification of efficacy and safety of bisphosphonates or denosumab for patients with osteoporosis after treatment with romosozumab

Kobayakawa Tomonori0 sites100 target enrollmentDecember 12, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kobayakawa Tomonori
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kobayakawa Tomonori

Eligibility Criteria

Inclusion Criteria

  • 1\. Primary osteoporosis
  • 2\. Patients who used romosozumab for 12 months
  • 3\. Written informed consent

Exclusion Criteria

  • 1\.Patients who are allergic to lomosozumab and ibandronate
  • 2\.hypocalcemia
  • 3\.Pregnant or breastfeeding women
  • 4\.Patients with reflux esophagitis, esophageal achalasia
  • 5\.Patients who cannot keep standing or sitting for more than 60 minutes
  • 6\.GFR30mL/min/1\.73m2 or less, Dialysis patients
  • 7\.Patients with upper gastrointestinal disorders such as dysphagia, esophagitis, gastritis, duodenal
  • inflammation, ulcers
  • 8\.Patients judg ed to be inappropriate for study

Outcomes

Primary Outcomes

Not specified

Similar Trials